REBECCA HAWTHORNE: Open Payments
NPI 1790155620 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $170 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $53 |
| Lilly USA, LLC | 2 | $36 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| EVOKE PHARMA, INC. | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: MOUNJARO, REZDIFFRA, JARDIANCE, Ozempic, Wegovy, GIMOTI, IBSRELA, REPATHA.
Industry payments across TX — which companies pay providers there.
